BR0303500A - Anticorpo monoclonal especìfico para um epìtope de glicoproteìna codificada pelo vìrus da imunodeficiência felina inativo - Google Patents

Anticorpo monoclonal especìfico para um epìtope de glicoproteìna codificada pelo vìrus da imunodeficiência felina inativo

Info

Publication number
BR0303500A
BR0303500A BR0303500-0A BR0303500A BR0303500A BR 0303500 A BR0303500 A BR 0303500A BR 0303500 A BR0303500 A BR 0303500A BR 0303500 A BR0303500 A BR 0303500A
Authority
BR
Brazil
Prior art keywords
monoclonal antibody
immunodeficiency virus
feline immunodeficiency
inactive
antibody specific
Prior art date
Application number
BR0303500-0A
Other languages
English (en)
Other versions
BR0303500B1 (pt
Inventor
Chengjin Michael Huang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0303500A publication Critical patent/BR0303500A/pt
Publication of BR0303500B1 publication Critical patent/BR0303500B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"ANTICORPO MONOCLONAL ESPECìFICO PARA UM EPìTOPE DE GLICOPROTEìNA CODIFICADA PELO VìRUS DA IMUNODEFICIêNCIA FELINA INATIVADO". A presente invenção fornece um anticorpo monocional específico para um epítope que é único para o componente de proteína superficial de uma glicoproteína do envelope do vírus da imunodeficiência felina (FIV) inativado. O referido anticorpo é útil para a quantificação de FIV inativado ou para a determinação da potência de uma vacina de FIV inativado.
BRPI0303500-0B1A 2002-09-12 2003-09-10 anticorpo monoclonal específico para um epítopo de glicoproteína codificada pelo vírus da imunodeficiência felina (fiv) inativado, linhagens de células e métodos para determinar a potência e quantidade de fiv, bem como para detectar um epítopo para glicoproteína codificada por fiv. BR0303500B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41024602P 2002-09-12 2002-09-12

Publications (2)

Publication Number Publication Date
BR0303500A true BR0303500A (pt) 2004-09-08
BR0303500B1 BR0303500B1 (pt) 2013-09-17

Family

ID=31888412

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0303500-0B1A BR0303500B1 (pt) 2002-09-12 2003-09-10 anticorpo monoclonal específico para um epítopo de glicoproteína codificada pelo vírus da imunodeficiência felina (fiv) inativado, linhagens de células e métodos para determinar a potência e quantidade de fiv, bem como para detectar um epítopo para glicoproteína codificada por fiv.

Country Status (22)

Country Link
US (1) US7345152B2 (pt)
EP (2) EP2281838A1 (pt)
JP (1) JP4472298B2 (pt)
KR (1) KR101114268B1 (pt)
CN (1) CN1528791B (pt)
AR (1) AR041230A1 (pt)
AT (1) ATE553126T1 (pt)
AU (2) AU2003246049A1 (pt)
BR (1) BR0303500B1 (pt)
CO (1) CO5500021A1 (pt)
CY (1) CY1112710T1 (pt)
DK (1) DK1398325T3 (pt)
ES (1) ES2383075T3 (pt)
HR (1) HRP20030729A2 (pt)
MX (1) MXPA03008083A (pt)
NZ (1) NZ528160A (pt)
PL (1) PL362164A1 (pt)
PT (1) PT1398325E (pt)
RS (1) RS51739B (pt)
SI (1) SI1398325T1 (pt)
TW (1) TW200406421A (pt)
ZA (1) ZA200307119B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101124315A (zh) 2003-01-17 2008-02-13 伊势龙医学股份有限公司 利用凝集素亲和性血液透析去除血液中病毒的方法
CN102735853B (zh) * 2012-06-07 2014-06-04 广州市华南农大生物药品有限公司 一种猪流感灭活疫苗的效价测定方法
CN108473539B (zh) * 2015-12-23 2022-03-22 英特维特国际股份有限公司 猫杯状病毒疫苗
CN110501509A (zh) * 2019-09-03 2019-11-26 长春西诺生物科技有限公司 一种抗猫细小病毒猫源化基因工程抗体elisa试剂盒及其检测方法
CN120965872B (zh) * 2025-10-21 2025-12-26 北京溯本源和生物科技有限公司 一种用于检测猫免疫缺陷病毒p24蛋白的单克隆抗体对及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341439C (en) * 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US6107077A (en) * 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
US5177014A (en) * 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
US6228608B1 (en) 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
GB9215233D0 (en) 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
WO1994020622A1 (en) 1993-03-11 1994-09-15 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
US6015686A (en) * 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
US6254872B1 (en) 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
ATE313629T1 (de) 1998-08-24 2006-01-15 Pfizer Prod Inc Immunschwächevirus stamm fiv-141 der katze und dessen verwendungen

Also Published As

Publication number Publication date
EP1398325A1 (en) 2004-03-17
KR101114268B1 (ko) 2012-03-05
JP4472298B2 (ja) 2010-06-02
DK1398325T3 (da) 2012-05-21
PL362164A1 (en) 2004-03-22
ZA200307119B (en) 2005-05-25
AU2010224370B2 (en) 2011-07-21
MXPA03008083A (es) 2004-11-29
AR041230A1 (es) 2005-05-11
EP1398325B1 (en) 2012-04-11
ES2383075T3 (es) 2012-06-18
AU2003246049A1 (en) 2004-04-01
RS51739B (sr) 2011-10-31
CN1528791A (zh) 2004-09-15
NZ528160A (en) 2005-07-29
US7345152B2 (en) 2008-03-18
TW200406421A (en) 2004-05-01
EP2281838A1 (en) 2011-02-09
CN1528791B (zh) 2012-09-05
US20040053224A1 (en) 2004-03-18
JP2004097225A (ja) 2004-04-02
HRP20030729A2 (en) 2005-02-28
ATE553126T1 (de) 2012-04-15
CO5500021A1 (es) 2005-03-31
YU71803A (sh) 2006-05-25
SI1398325T1 (sl) 2012-06-29
KR20040024490A (ko) 2004-03-20
BR0303500B1 (pt) 2013-09-17
PT1398325E (pt) 2012-05-29
CY1112710T1 (el) 2016-02-10
AU2010224370A1 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
BR0316670A (pt) Anticorpos quiméricos e humanizados para integrina (alfa)5ß1 que modulam a angiogênese
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
MXPA01012662A (es) Deteccion temprana de flavivirus que utiliza la glicoproteina ns1.
AR063780A2 (es) Un anticuerpo aislado composicion farmaceutica que lo comprende y metodo para inhibir la actividad de y detectar una interleuquina
BR0314814A (pt) Variantes otimizadas de fc e métodos para sua geração
ATE417275T1 (de) Puffern zur stabilizierung von hcv antigenen
ECSP045300A (es) Antígenos virales
NO20001238L (no) Monoklonalt antistoff som induserer apoptose
PT1557462E (pt) Células de indução da aceitação de um transplante de origem monocítica e a sua preparação e utilização
ES2074062T3 (es) Inmunoensayo para antigenos hiv-1 que utilizan fragmentos de f(ab')2 como sonda.
BR9912702A (pt) Composto e método para a prevenção e/ou para o tratamento de alergias
DK2006301T3 (da) Peptid-baseret immuniseringsterapi til behandling af atherosklerose
BR112021016619A2 (pt) Anticorpo capaz de se ligar à calreticulina mutante de forma clivada e agente de diagnóstico, profilático ou terapêutico para neoplasmas mieloproliferativos
ES2066887T3 (es) Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1.
MX2024009860A (es) Anticuerpos monoclonales humanos que se dirigen ampliamente a los coronavirus
BRPI0513237A (pt) hidrolisados de proteìna para diminuição de pressão sanguìnea
ATE556717T1 (de) Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus
NO20044051L (no) Analyse for ACTRIIB-kinase aktivitet
BR112022001693A2 (pt) Construtos de proteína de ligação ao antígeno e usos dos mesmos
MX2021012695A (es) Vacuna de subunidad del virus de la fiebre porcina clasica (csfv).
BR0113213A (pt) Método para diagnosticar uma doença auto-imune, anticorpo, composição de diagnóstico, e, uso do anticorpo
CY1114614T1 (el) Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
PE20230075A1 (es) Anticuerpos anti-flt3 y composiciones
BR0303500A (pt) Anticorpo monoclonal especìfico para um epìtope de glicoproteìna codificada pelo vìrus da imunodeficiência felina inativo
MX2022013030A (es) Ensayos de deteccion para anticuerpos neutralizantes de coronavirus.

Legal Events

Date Code Title Description
B03H Publication of an application: rectification [chapter 3.8 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/09/2013, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B25A Requested transfer of rights approved
B25D Requested change of name of applicant approved
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.